Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents
Sign Up to like & getrecommendations! Published in 2020 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-020-05166-5
Abstract: Background Despite successful clinical outcomes of biologic medications in patients with chronic rheumatic diseases, some considerable adverse effects such as infections remain a major concern. Possibility of tuberculosis (TB) reactivation over treatment with anti-tumor necrotizing… read more here.
Keywords: alpha agents; tnf alpha; treatment; treatment anti ... See more keywords